Accretion Nutraveda H1 FY27 Revenue Surges 109% to ₹29.44 Cr

Accretion Nutraveda Limited announced its unaudited financial results for the half-year ended September 30, 2026. The company reported a significant year-over-year (YoY) growth, with Net Revenue increasing by 109.35% to ₹29.44 crore from ₹14.06 crore in H1 FY26. EBITDA grew by 88.03% YoY to ₹6.26 crore, while Profit After Tax (PAT) surged by 98.66% YoY to ₹4.73 crore. The strong performance was attributed to increased demand for nutraceutical, ayurvedic, and wellness products, operational expansion, and expanding market presence. The company highlighted its integrated manufacturing capabilities and a diverse portfolio of over 200 products, with a focus on expanding its Contract Development and Manufacturing Organisation (CDMO) business and international presence.